![Spruce Biosciences Inc](/common/images/company/N_SPRB.png)
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease ... Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH). Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0142 | 3.67114788004 | 0.3868 | 0.4234 | 0.3705 | 583963 | 0.39966721 | CS |
4 | 0.05 | 14.245014245 | 0.351 | 0.4234 | 0.3502 | 353325 | 0.38560614 | CS |
12 | -0.0706 | -14.9703138253 | 0.4716 | 0.574 | 0.3421 | 615231 | 0.43180728 | CS |
26 | -0.048 | -10.6904231626 | 0.449 | 0.608 | 0.3421 | 491796 | 0.45588004 | CS |
52 | -4.009 | -90.9070294785 | 4.41 | 5.95 | 0.3421 | 704377 | 0.91976552 | CS |
156 | -1.829 | -82.0179372197 | 2.23 | 5.95 | 0.3421 | 436722 | 1.57414715 | CS |
260 | -16.599 | -97.6411764706 | 17 | 35.6 | 0.3421 | 547572 | 3.22036069 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.